Cerebriu is required by the FDA to review a change control plan for an AI-enabled device in the US.

Cerebriu’s proven radiology AI solutions detect findings during the initial scan and enable the most appropriate procedures while the patient is still in the scanner. This leads to a simpler, faster MR image acquisition and creates tangible clinical value: Improving technologists’ confidence and freeing up radiologists’ time by ensuring the right data the first time the patient is in the scanner Timely diagnosis of critical findings by prioritizing radiologists’ worklists Improving patient experience and reducing patient recalls